Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
DOI: | 10.33448/rsd-v10i14.22188 |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/22188 |
Resumo: | The objective of this review was to assess the effects of vitamin D supplementation in patients affected by COVID-19. In the methodology, a survey was carried out by means of an electronic search in data banks LILACS, PubMed and Cochrane, by articles published in 2020 and 2021. In the initial electronic search, 241 articles were identified in the PubMed base, 68 articles in Cochrane and 3 articles in LILACS on the subject. In the first screening, 187 studies were selected and 125 were excluded by not presenting the words “covid” and “vitamin D”, not title and / or summary. In the second screening, 177 articles were excluded and 10 studies were selected for inclusion in the review. As a result, 4 two 10 included patients with mild COVID-19, while 2 involved patients in serious condition. In relation to life, a majority of two studies involve patients with advanced eating and comorbidities, such as diabetes and hypertension. As a conclusion, vitamin D supplementation is most effective in mild to moderate COVID-19 patients, mainly in patients who had vitamin supplementation before being treated for the disease. Regarding patients with severe COVID-19, the events will show that high doses can generate rapid and satisfactory effects, without time of hospitalization, therefore, or late start of supplementation can be a limiting factor. |
id |
UNIFEI_db7da112f41acebb3b0b31d84d1310a0 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/22188 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
spelling |
Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic reviewEvidencia científica sobre la suplementación de vitamina D en pacientes afectados por COVID-19: una revisión bibliográfica integrativaEvidências científicas sobre a suplementação de vitamina D em pacientes acometidos por COVID-19: uma revisão bibliográfica integrativaCOVID-19Vitamin DSupplementation.COVID-19Vitamina DSuplementación.Covid19 Vitamin DSuplementação.The objective of this review was to assess the effects of vitamin D supplementation in patients affected by COVID-19. In the methodology, a survey was carried out by means of an electronic search in data banks LILACS, PubMed and Cochrane, by articles published in 2020 and 2021. In the initial electronic search, 241 articles were identified in the PubMed base, 68 articles in Cochrane and 3 articles in LILACS on the subject. In the first screening, 187 studies were selected and 125 were excluded by not presenting the words “covid” and “vitamin D”, not title and / or summary. In the second screening, 177 articles were excluded and 10 studies were selected for inclusion in the review. As a result, 4 two 10 included patients with mild COVID-19, while 2 involved patients in serious condition. In relation to life, a majority of two studies involve patients with advanced eating and comorbidities, such as diabetes and hypertension. As a conclusion, vitamin D supplementation is most effective in mild to moderate COVID-19 patients, mainly in patients who had vitamin supplementation before being treated for the disease. Regarding patients with severe COVID-19, the events will show that high doses can generate rapid and satisfactory effects, without time of hospitalization, therefore, or late start of supplementation can be a limiting factor.El objetivo de esta revisión fue evaluar los efectos de la suplementación con vitamina D en pacientes afectados por COVID-19. En la metodología, se realizó una encuesta mediante búsqueda electrónica en las bases de datos LILACS, PubMed y Cochrane, para artículos publicados en 2020 y 2021 En la búsqueda electrónica inicial se identificaron 241 artículos en la base de datos PubMed, 68 artículos en Cochrane y 3 artículos en LILACS sobre el tema. En la primera selección, se seleccionaron 187 estudios y se excluyeron 125 por no tener las palabras “covid” y “vitamina D” en el título y / o resumen. En la segunda selección, se excluyeron 177 artículos y se seleccionaron 10 estudios para su inclusión en la revisión. Como resultado, 4 de los 10 incluyeron pacientes involucrados con COVID-19 leve, mientras que 2 involucraron pacientes en una condición severa. En cuanto a la edad, la mayoría de los estudios involucran a pacientes con edad avanzada y comorbilidades como diabetes e hipertensión. En conclusión, la suplementación con vitamina D es más eficaz en pacientes con COVID-19 de un nivel moderado a moderado, especialmente en pacientes que ya estaban tomando suplementos de vitamina D antes de verse afectados por la enfermedad. En cuanto a los pacientes con COVID-19 grave, la evidencia ha demostrado que las dosis altas pueden generar efectos rápidos y satisfactorios sobre la duración de la estancia, pero el inicio tardío de la suplementación puede ser un factor limitante.O objetivo dessa revisão foi avaliar os efeitos da suplementação de vitamina D em pacientes acometidos por COVID-19. Na metodologia, foi realizado um levantamento por meio de busca eletrônica nos bancos de dados LILACS, PubMed e Cochrane, por artigos publicados em 2020 e 2021. Na pesquisa eletrônica inicial foi identificado 241 artigos na base PubMed, 68 artigos na Cochrane e 3 artigos na LILACS sobre o tema. Na primeira triagem, 187 estudos foram selecionados e 125 foram excluídos por não apresentarem as palavras “covid” e “vitamina D” no título e/ou resumo. Na segunda triagem, 177 artigos foram excluídos e 10 estudos foram selecionados para inclusão na revisão. Como resultado, 4 dos 10 incluídos envolveram pacientes com COVID-19 leve, enquanto 2 envolveram pacientes em estado grave. Em relação à idade, a maioria dos estudos envolvem pacientes com idade avançada e com comorbidades, como diabetes e hipertensão. Como conclusão, a suplementação de vitamina D é mais eficaz em pacientes com COVID-19 de leve a moderada, principalmente em pacientes que já faziam suplementação da vitamina antes de serem acometidos pela doença. Sobre os pacientes com COVID-19 grave, as evidências mostraram que altas doses podem gerar efeitos rápidos e satisfatórios no tempo de internação, porém o início tardio da suplementação pode ser um fator limitador.Research, Society and Development2021-11-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2218810.33448/rsd-v10i14.22188Research, Society and Development; Vol. 10 No. 14; e485101422188Research, Society and Development; Vol. 10 Núm. 14; e485101422188Research, Society and Development; v. 10 n. 14; e4851014221882525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/22188/19809Copyright (c) 2021 Isaac Hidekishimada da Silva Rocha; Liejy Agnes dos Santos Raposo Landim https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRocha, Isaac Hidekishimada da Silva Landim , Liejy Agnes dos Santos Raposo 2021-12-04T11:48:39Zoai:ojs.pkp.sfu.ca:article/22188Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:41:25.151842Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review Evidencia científica sobre la suplementación de vitamina D en pacientes afectados por COVID-19: una revisión bibliográfica integrativa Evidências científicas sobre a suplementação de vitamina D em pacientes acometidos por COVID-19: uma revisão bibliográfica integrativa |
title |
Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review |
spellingShingle |
Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review Rocha, Isaac Hidekishimada da Silva COVID-19 Vitamin D Supplementation. COVID-19 Vitamina D Suplementación. Covid19 Vitamin D Suplementação. Rocha, Isaac Hidekishimada da Silva COVID-19 Vitamin D Supplementation. COVID-19 Vitamina D Suplementación. Covid19 Vitamin D Suplementação. |
title_short |
Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review |
title_full |
Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review |
title_fullStr |
Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review |
title_full_unstemmed |
Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review |
title_sort |
Scientific evidence on vitamin D supplementation in patients affected by COVID-19: an integrative bibliographic review |
author |
Rocha, Isaac Hidekishimada da Silva |
author_facet |
Rocha, Isaac Hidekishimada da Silva Rocha, Isaac Hidekishimada da Silva Landim , Liejy Agnes dos Santos Raposo Landim , Liejy Agnes dos Santos Raposo |
author_role |
author |
author2 |
Landim , Liejy Agnes dos Santos Raposo |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Rocha, Isaac Hidekishimada da Silva Landim , Liejy Agnes dos Santos Raposo |
dc.subject.por.fl_str_mv |
COVID-19 Vitamin D Supplementation. COVID-19 Vitamina D Suplementación. Covid19 Vitamin D Suplementação. |
topic |
COVID-19 Vitamin D Supplementation. COVID-19 Vitamina D Suplementación. Covid19 Vitamin D Suplementação. |
description |
The objective of this review was to assess the effects of vitamin D supplementation in patients affected by COVID-19. In the methodology, a survey was carried out by means of an electronic search in data banks LILACS, PubMed and Cochrane, by articles published in 2020 and 2021. In the initial electronic search, 241 articles were identified in the PubMed base, 68 articles in Cochrane and 3 articles in LILACS on the subject. In the first screening, 187 studies were selected and 125 were excluded by not presenting the words “covid” and “vitamin D”, not title and / or summary. In the second screening, 177 articles were excluded and 10 studies were selected for inclusion in the review. As a result, 4 two 10 included patients with mild COVID-19, while 2 involved patients in serious condition. In relation to life, a majority of two studies involve patients with advanced eating and comorbidities, such as diabetes and hypertension. As a conclusion, vitamin D supplementation is most effective in mild to moderate COVID-19 patients, mainly in patients who had vitamin supplementation before being treated for the disease. Regarding patients with severe COVID-19, the events will show that high doses can generate rapid and satisfactory effects, without time of hospitalization, therefore, or late start of supplementation can be a limiting factor. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-11-10 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/22188 10.33448/rsd-v10i14.22188 |
url |
https://rsdjournal.org/index.php/rsd/article/view/22188 |
identifier_str_mv |
10.33448/rsd-v10i14.22188 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/22188/19809 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Isaac Hidekishimada da Silva Rocha; Liejy Agnes dos Santos Raposo Landim https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Isaac Hidekishimada da Silva Rocha; Liejy Agnes dos Santos Raposo Landim https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 14; e485101422188 Research, Society and Development; Vol. 10 Núm. 14; e485101422188 Research, Society and Development; v. 10 n. 14; e485101422188 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1822178468481204224 |
dc.identifier.doi.none.fl_str_mv |
10.33448/rsd-v10i14.22188 |